Study: Increased Rates of Cervical Cancer in Sweden Linked to Increase in HPV Vaccinations
By Brian Shilhavy
Editor, Health Impact News
A new study published in the Indian Journal of Medical Ethics examined cervical cancer rates among women in Sweden and discovered a link between increased cervical cancer rates among women aged 20-49 during a two-year period between 2014 and 2015, corresponding to increased HPV vaccination rates in this population group, years earlier, when mass HPV vaccinations started in Sweden.
Women above the age of 50, during this two-year period, saw no significant cervical cancer increase and were likely too old to have been vaccinated with the HPV vaccine.
Since the study casts doubt on the efficacy of the HPV vaccine, and, in fact, links the vaccine to increased cancer rates, it is highly unlikely you will read about this in the U.S. corporate-sponsored media, where nothing negative about the blockbuster HPV Gardasil vaccine is allowed.
The study was conducted by Lars Andersson, PhD, from the Department of Physiology and Pharmacology at the Karolinska Institute in Solna, Sweden.
Dr. Andersson states that:
…when the Swedish media discussed the increase in the incidence of cervical cancer, the health authorities were unable to explain the increase.
So Dr. Andersson discussed the possibility that mass HPV vaccination rates actually could be the cause of increased rates of cervical cancer:
HPV vaccination could play a role in the increase in the incidence of cervical cancer. About 25% of cervical cancers have a rapid onset of about three years including progression from normal cells to cancer.
Therefore, an increase may be seen within a short period of time.
Gardasil was approved in Sweden in 2006. In 2010, the vaccination of a substantial number of girls started. In 2010, about 80% of the 12-year-old girls were vaccinated.
Combined with 59% of the 13–18-year-old girls vaccinated through the catch-up programme in the same period, one can say that most girls were vaccinated.
Thus, the oldest girls in the programme were 23 years old in 2015; and this is well within the younger age group shown in Fig. 1.
Dr. Andersson points out that even the FDA’s own analysis of Gardasil in 2006 showed a higher risk of “premalignant cell changes” from the vaccine in certain groups that had already been exposed to some HPV strains:
Read more here.
Controversy has arisen around the Indian Journal of Medical Ethics article because the author had submitted under a false name to escape professional persecution. After consideration the the journal's editors decided not to retract the article and made the following statement:-
On May 8, the KI informed us that its department of physiology and pharmacology did not have any person of this name and requested us to remove the name of the institution. So, on the same day a correction was carried out and the name of KI was removed and duly intimated to KI.
Since then, we have investigated and learned the identity of the author. The author has said that he used a pseudonym because he believed the use of his real name would have invited personal repercussions from those opposed to any questioning of vaccines.
This deception of the journal’s editors is unacceptable. The author could have asked the editors for confidentiality, giving the reasons. Editors may choose to publish articles without revealing the true name of the author, if it is determined that the circumstances justify it.
However, we considered the matter and decided to keep the article on the site as the issues raised by it are important and discussion on it is in the public interest. The author’s true name is withheld at his request.